ArticlePloS one2022

Serum proteomic profiling reveals MTA2 and AGO2 as potential prognostic biomarkers associated with disease activity and adverse outcomes in multiple myeloma.

Dollapak Apipongrat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.